• Explore /
  • Poster
  • / INNOVATE (NRG-GU008): A randomized phase III trial of salvage radiotherapy and androgen deprivation therapy (ADT) with/without abiraterone and apalutamide for patients with node-positive prostate cancer after radical prostatectomy.

INNOVATE (NRG-GU008): A randomized phase III trial of salvage radiotherapy and androgen deprivation therapy (ADT) with/without abiraterone and apalutamide for patients with node-positive prostate cancer after radical prostatectomy.

Abstract Poster

Authors

null

Ronald C. Chen

University of Kansas, Kansas City, KS

Ronald C. Chen , Theodore Karrison , Colleen Anne Lawton , William Adrian Hall , Hala Borno , Mihaela Rosu , Ashesh B. Jani , David M. Schuster , Michael J. Seider , Jason A. Efstathiou , Edwin Melencio Posadas , Paul L. Nguyen , Felix Y Feng

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session: Advanced Prostate Cancer

Track

Prostate Cancer - Advanced

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04134260

Citation

J Clin Oncol 39, 2021 (suppl 6; abstr TPS179)

DOI

10.1200/JCO.2021.39.6_suppl.TPS179

Abstract #

TPS179

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Rahul Raj Aggarwal

First Author: Daniel J. George

First Author: Diogo Assed Bastos

First Author: Tian Zhang